Cardiometabolic and atherosclerotic cardiovascular disease outcomes associated with tirzepatide: insights from a 1-year multicenter observational study

Journal of the Endocrine Society
- Tirzepatide
- Lipid and ceramide metabolism
- Atherosclerotic cardiovascular disease
- Obesity
- Overweight
- Humans
The paper
René de Jesús Rivera Gutiérrez, Regina Castaneda, Alfredo Verastegui, Maria Daniela Hurtado
Show 7 more authors
Wissam Ghusn, Dima Bechenati, Maria Espinosa, Jose L. Villamarin, Elif Tama, Kristen Frederiksen, Andres J Acosta,Jacksonville College
Journal of the Endocrine Society · 9 Sep 2026